Szrama Jakub, Kusza Krzysztof, Sobczyński Paweł, Molnar Zsolt, Siemionow Maria
Department of Anesthesiology and Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland.
Chair and Department of Anesthesiology and Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland.
Postepy Kardiol Interwencyjnej. 2022 Dec;18(4):459-464. doi: 10.5114/aic.2021.110926. Epub 2021 Nov 17.
The purpose of this review was to summarize the anti-inflammatory and immunosuppressive properties of volatile anesthetics and present their potential impact on the outcomes of major surgical procedures as well as microsurgical cases of free tissue transfer. Inhaled anesthetics are commonly used as a component of general anesthesia in interventional procedures, reconstructive surgery, free tissue transfers and transplantation. Experimental and clinical studies have shown that volatile anesthetics such as halothane, sevoflurane, isoflurane or desflurane can affect the immune system of patients exposed to general anesthesia. In patients with no serious systemic diseases, this effect is transient and mostly clinically irrelevant. However, in patients subjected to the inflammatory response due to the active disease, cardiac or pulmonary failure or advanced age, the prognosis may improve or worsen following inhalation anesthesia depending on the type of systemic pathology. The available data from reported clinical trials, as well as the and experimental studies, have often reported conflicting statements regarding the impact of inhalation anesthetics on outcomes of surgical procedures. These differences may be due to the heterogeneity of the evaluated patients, the extent and duration of surgical procedures, and different experimental design and methodologies applied for assessment of the reported clinical and research studies. In this review, based on the available literature reports we have summarized the anti-inflammatory and immunosuppressive effects as well as cellular responses of inhalation anesthetics at the microcirculatory level and discussed their potential clinical implications for the outcomes of surgical procedures of free tissue transfers.
本综述的目的是总结挥发性麻醉剂的抗炎和免疫抑制特性,并阐述其对大型外科手术以及游离组织移植显微外科手术结局的潜在影响。吸入麻醉剂常用于介入手术、重建手术、游离组织移植和移植手术中的全身麻醉。实验和临床研究表明,氟烷、七氟烷、异氟烷或地氟烷等挥发性麻醉剂可影响接受全身麻醉患者的免疫系统。在无严重全身性疾病的患者中,这种影响是短暂的,大多在临床上无相关性。然而,在因活动性疾病、心脏或肺功能衰竭或高龄而发生炎症反应的患者中,吸入麻醉后预后可能改善或恶化,这取决于全身病理类型。已报道的临床试验以及实验研究的现有数据,在吸入麻醉剂对手术结局的影响方面常常存在相互矛盾的说法。这些差异可能归因于所评估患者的异质性、手术的范围和持续时间,以及用于评估所报道临床和研究的不同实验设计和方法。在本综述中,基于现有文献报道,我们总结了吸入麻醉剂在微循环水平的抗炎和免疫抑制作用以及细胞反应,并讨论了它们对游离组织移植手术结局的潜在临床意义。